Designing CD4 immunoadhesins for AIDS therapy
- PMID: 2536900
- DOI: 10.1038/337525a0
Designing CD4 immunoadhesins for AIDS therapy
Abstract
A newly-constructed antibody-like molecule containing the gp120-binding domain of the receptor for human immunodeficiency virus blocks HIV-1 infection of T cells and monocytes. Its long plasma half-life, other antibody-like properties, and potential to block all HIV isolates, make it a good candidate for therapeutic use.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials